A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2004
10/21/2004	WO2004089417A1 Drug-enclosing multilayer structure particulate and process for producing the same
10/21/2004	WO2004089398A1 Fungal vacuolar proteins as a target for antifugal agents
10/21/2004	WO2004089396A2 Anti-fungal peptidomimetics
10/21/2004	WO2004089383A1 Pharmaceutical combinations comprising lamivudine, stavudine and efavirenz for treating viral infections
10/21/2004	WO2004089382A1 Pharmaceutical combinations comprising lamivudine, zidovudine and efavirenz for treating viral infections
10/21/2004	WO2004089378A1 Medicinal composition containing pyrrolopyridazine derivative
10/21/2004	WO2004089357A2 Anti-fungal formulation of triterpene and essential oil
10/21/2004	WO2004089341A1 Organic compounds
10/21/2004	WO2004089305A2 Heparin/heparosan synthase from p.multocida, soluble and single action catalysts thereof and methods of making and using same
10/21/2004	WO2004089282A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/21/2004	WO2004081024A3 Anti-microbial peptide known as halocyntin, gene coding for said peptide, vector, transformed organism and composition containing said peptide
10/21/2004	WO2004078912A3 Chicken rna polymerase i promoter and the use thereof
10/21/2004	WO2004069832A3 Antibacterial agents
10/21/2004	WO2004058144A3 Antibacterial agents
10/21/2004	WO2004056871A3 Peptides and their use for the treatment of hiv infections
10/21/2004	WO2004056843A3 10-substituted macrolide antibiotics
10/21/2004	WO2004043428A3 Buccal, polar and non-polar spray or capsule containing drugs for treating pain
10/21/2004	WO2004039808A3 Process for the preparation of ganciclovir
10/21/2004	WO2004032832A3 Bispecific molecule comprising an anti-cr1 antibody cross-linked to an antigen-binding antibody fragment
10/21/2004	WO2004006867A3 2-amino-9-[(2-hydroxymethyl) cyclopropylidenemethyl] purine antiviral agents
10/21/2004	WO2003097163A3 Using a selective inos inhibitor for the treatment of respiratory diseases and conditions
10/21/2004	WO2003072757A9 Nucleotide mimics and their prodrugs
10/21/2004	WO2003045228A3 Methods for treating autoimmune disorders, and reagents related thereto
10/21/2004	US20040210052 Efficient synthesis of 5-heteroatom-containing-pyrazoles
10/21/2004	US20040209940 potent antibacterial activity against various bacteria including drug-resistant strains
10/21/2004	US20040209935 Pyrazole-derived kinase inhibitors and uses thereof
10/21/2004	US20040209927 administering a aminostilbazole, e.g., E)-4-[2-{2-[N-acetyl-N-(4-methoxybenzenesulfonyl)amino]phenyl}ethenyl]pyridine 1-oxide as a Vpr function regulator, useful in the treatment of HIV or AIDS,
10/21/2004	US20040209914 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
10/21/2004	US20040209908 New derivatives of hydantoins, thiohydantoins, pyrimidinediones and thioxopyrimidinones, their preparation processes and their use as medicaments
10/21/2004	US20040209901 substituted 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds, e.g., 8-(2,6-Difluoro-phenyl)-4-(4-fluoro-2-methyl-phenyl)-2-(2-hydroxy-1-hydroxymethyl-ethylamino)-8H-pyrido[2,3-d]pyrimidin-7-one; CSBP/p38 kinase inhibitors.
10/21/2004	US20040209879 Piperidinyl derivates as modulators of chemokine receptor activity
10/21/2004	US20040209874 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE)
10/21/2004	US20040209868 Substituted indoles
10/21/2004	US20040209826 Diphosphate salt of a "4" - substituted-9-deoxo-9 A - AZA - homoerythromycin derivatives and its pharmaceutical composition
10/21/2004	US20040209319 Using high throughput assays which monitor phosphorylation and dephosphorylation of proteins to identify drugs for use as bactericides against infectious microorganisms
10/21/2004	US20040209244 Anti-dengue virus antibodies, compositions, methods and uses
10/21/2004	US20040208924 active pharmaceutical ingredient is for example [(2S)-Sulfanyl-5-[(N,N-dimethylamino)acetyl]aminopentanoyl-L-leucyl-L-tert-leucine N-methylamide; bonding strength, stability
10/21/2004	US20040208901 Methods for preventing cattle reproductive diseases
10/21/2004	US20040208900 mutant rabies virus comprising a rabies virus N protein that is not phosphorylated; central nervous system (CNS)
10/21/2004	US20040208896 Immunotherapy for humans
10/21/2004	US20040208895 administering HETEROLOGOUS GENE PRODUCTS IN HOST CELL SYSTEMS AND/OR TO RESCUE NEGATIVE STRAND RNA RECOMBINANT VIRUSES
10/21/2004	US20040208889 Pharmaceutical use for secreted bacterial effector proteins
10/21/2004	US20040208888 Method of and compositions for immunization with the pseudomonas v antigen
10/21/2004	US20040208882 Ltb4 as vaccine adjuvant
10/21/2004	US20040208860 Use of emu oil and its various fractions as a carrier for antifungal, antibacterial, and antiviral medications & preparations
10/21/2004	US20040208854 Methods and compositions for controlled release of bioactive compounds
10/21/2004	US20040208851 Immunization by inoculation of DNA transcription unit
10/21/2004	US20040208844 Products and drug delivery vehicles
10/21/2004	US20040208834 Oral-use polymer and oral-use composition
10/21/2004	DE102004016947A1 Feste pharmazeutische Zusammensetzung A solid pharmaceutical composition
10/21/2004	DE102004010690A1 Gesundheitsfördernde Zusammensetzungen aus lipidhaltigen Pilzen und Thiocyanaten Health-promoting compositions of lipid-containing mushrooms and thiocyanates
10/21/2004	CA2707750A1 Solid pharmaceutical compositions comprising a s1p receptor agonist and a sugar alcohol
10/21/2004	CA2521856A1 Severe acute respiratory syndrome (sars) causing coronavirus
10/21/2004	CA2521713A1 Anti-fungal peptidomimetics
10/21/2004	CA2521685A1 Antimicrobial [3.1.0] bicyclohexylphenyl-oxazolidinone derivatives and analogues
10/21/2004	CA2521653A1 Aromatic sulfonamides as peroxynitrite-rearrangement catalysts
10/21/2004	CA2519794A1 Novel carbapenem compounds
10/21/2004	CA2426280A1 Methods for preventing cattle reproductive diseases
10/20/2004	EP1469308A1 Method of screening drug
10/20/2004	EP1469011A1 Hemoglobin conjugates
10/20/2004	EP1469008A1 Method of preparing a non-pharmaceutical grade clarithromycin
10/20/2004	EP1469007A1 Sulfoglycolipid antigens, their extraction from mycobacterieum tuberculosis, and their use against tuberculosis
10/20/2004	EP1468991A1 Imides as PDE III, PDE IV and TNF inhibitors
10/20/2004	EP1468697A1 Compositions containing piperacillin and tazobactam useful for injection
10/20/2004	EP1468119A2 A METHOD OF DEVELOPING AN ANTI−PROTEIN AND REGULATION OF A CELLULAR FUNCTION BY ADMINISTERING AN EFFECTIVE AMOUNT OF THE ANTI−PROTEIN
10/20/2004	EP1468098A2 Method of inhibiting pathogenicity of infectious agents
10/20/2004	EP1468097A2 METHODS OF GENERATING MULTISPECIFIC, MULTIVALENT AGENTS FROM V sb H /sb AND V sb L /sb DOMAINS
10/20/2004	EP1468091A2 Transmembrane protein
10/20/2004	EP1468075A1 Novel lactobacillus sp. strain and use thereof
10/20/2004	EP1468020A2 Multimers of receptor-binding ligands
10/20/2004	EP1468019A2 Secreted protein
10/20/2004	EP1468018A2 Leptin proteins
10/20/2004	EP1467999A1 Oxothieno[3,2-b]pyridinecarboxamides as antiviral agents
10/20/2004	EP1467992A1 Antimicrobial dihydrothiazine and dihydrothiopyran oxazolidinones
10/20/2004	EP1467989A1 Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatitis c virus infection
10/20/2004	EP1467977A1 Novel antibacterial compounds:process for their preparation and pharmaceutical compositions containing them.
10/20/2004	EP1467976A1 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
10/20/2004	EP1467972A1 Indazole compounds useful as protein kinase inhibitors
10/20/2004	EP1467970A1 Hydroxynaphthyridinone carboxamides useful as hiv integrase inhibitors
10/20/2004	EP1467969A2 Dna minor groove binding compounds
10/20/2004	EP1467771A2 Mycobacterial vaccine
10/20/2004	EP1467766A1 Dermatological water-resistant compositions with sun screens and method for production and use of such compositions
10/20/2004	EP1467765A2 Combination therapy for the treatment of bacterial infections
10/20/2004	EP1467759A2 Compositions and methods related to tim-3, a th1-specific cell surface molecule
10/20/2004	EP1467754A1 Construction of west nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by west nile virus
10/20/2004	EP1467753A2 Recombinant herpesvirus of turkeys and use thereof
10/20/2004	EP1467752A1 HUMAN MAST CELL−EXPRESSED MEMBRANE PROTEINS
10/20/2004	EP1467744A2 Aqueous compositions containing metronidazole
10/20/2004	EP1467743A1 Pharmaceutical combinations comprising a fungicide, a bacteriostatic sulphonamide and an antibacterial compound for topical application
10/20/2004	EP1467741A1 Pharmaceutically acceptable phosphate-glycerol carrying bodies
10/20/2004	EP1467740A1 Phospholipid bodies and use thereof in the treatment of inflammatory and autoimmune diseases
10/20/2004	EP1467734A1 Cotherapy with an oxazolidinone and a vitamin b
10/20/2004	EP1467721A2 Substituted amine derivatives and their use for the treatment of angiogenesis
10/20/2004	EP1467714A1 Drug mixture with enhanced dissolution rate
10/20/2004	EP1467695A2 Hiv integrase inhibitors
10/20/2004	EP1467625A1 Adhesion inhibition of moulds
10/20/2004	EP1305033B1 Pharmaceutical compositions containing tobramycin and xanthan gum
10/20/2004	EP1263725B1 Novel compounds
10/20/2004	EP1230236B1 Compound with growth hormone releasing properties
10/20/2004	EP1217902B1 Nutritional compositions which contain non-digestible polysaccharides and use thereof to reduce transport through tight junctions

1 ... 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 ... 1798